Animal testing is costly, slow, and poorly predictive. ORIVA offers a human-relevant alternative with the potential to change that.

Sam Altman and husband reportedly working to genetically engineer babies from having hereditary disease - Sam Altman and his ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

According to a Wall Street Journal report, the company Preventive is working toward genetically engineering its first baby ...